Market Closed -
Other stock markets
|
After market 04:57:47 pm | |||
2.11 EUR | -0.47% | 2.12 | +0.47% |
07:30am | Medigene Ag Provides Earnings Guidance for 2024 | CI |
Mar. 04 | Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety and Efficacy | CI |
Sales 2023 * | 5.5M 5.93M | Sales 2024 * | 11.5M 12.4M | Capitalization | 52.07M 56.14M |
---|---|---|---|---|---|
Net income 2023 * | -18M -19.41M | Net income 2024 * | -12M -12.94M | EV / Sales 2023 * | 9.1 x |
Net cash position 2023 * | 2M 2.16M | Net Debt 2024 * | 17M 18.33M | EV / Sales 2024 * | 6.01 x |
P/E ratio 2023 * |
-2.75
x | P/E ratio 2024 * |
-5.37
x | Employees | 87 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 96.46% |
Latest transcript on Medigene AG
1 day | +4.25% | ||
1 week | +9.00% | ||
Current month | +48.81% | ||
1 month | +50.34% | ||
3 months | +51.92% | ||
6 months | +23.16% | ||
Current year | +42.95% |
Managers | Title | Age | Since |
---|---|---|---|
Selwyn Ho
CEO | Chief Executive Officer | 53 | 22-07-24 |
Chief Tech/Sci/R&D Officer | - | 14-04-30 | |
René Goedkoop
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 16-08-11 | |
Frank Mathias
BRD | Director/Board Member | 62 | 18-05-14 |
Anthony Man
BRD | Director/Board Member | 68 | 20-12-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 2.11 | -0.47% | 123 601 |
24-03-27 | 2.12 | -10.17% | 56,527 |
24-03-26 | 2.36 | -13.24% | 171,348 |
24-03-25 | 2.72 | +15.74% | 234,877 |
24-03-22 | 2.35 | +17.50% | 191,378 |
Delayed Quote Xetra, March 28, 2024 at 05:36 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.95% | 56.34M | |
+2.56% | 108B | |
+10.02% | 104B | |
+7.45% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |